vimarsana.com

Latest Breaking News On - Retina consultants - Page 4 : vimarsana.com

Oral APX3330 Receives FDA Nod for Phase 3 Endpoint in Diabetic Retinopathy

Ocuphire's end-of-phase 2 meeting with the FDA supports APX3330's phase 3 advancement, with 3-step worsening in binocular DRSS score as the primary endpoint.

Diabetic Retinopathy Usually No Worse With Semaglutide in T2D

Few eyes with no or background DR or mild or moderate nonproliferative diabetic retinopathy have worsening of DR at 3, 6, 12, 24 months.

Study Shows Tarcocimab May Improve Diabetic Retinopathy

AAO: Diabetic Retinopathy Usually No Worse With Semaglutide in T2D

THURSDAY, Nov. 9, 2023 (HealthDay News) For patients with type 2 diabetes mellitus, most eyes have no worsening of diabetic retinopathy (DR) after initiation of semaglutide, according to a study presented at the annual meeting of the American Academy of Ophthalmology, held from Nov. 3 to 6 in San Francisco. Zeeshan Haq, M.D., from

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.